GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Copland Road Capital Corp (XCNQ:CRCC) » Definitions » Debt-to-Revenue

Copland Road Capital (XCNQ:CRCC) Debt-to-Revenue : N/A (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Copland Road Capital Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Copland Road Capital's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.00 Mil. Copland Road Capital's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.00 Mil. Copland Road Capital's annualized Revenue for the quarter that ended in Dec. 2023 was C$0.00 Mil.


Copland Road Capital Debt-to-Revenue Historical Data

The historical data trend for Copland Road Capital's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Copland Road Capital Debt-to-Revenue Chart

Copland Road Capital Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.43 N/A N/A N/A N/A

Copland Road Capital Quarterly Data
Jan19 Apr19 Jul19 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of Copland Road Capital's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Copland Road Capital's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Copland Road Capital's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Copland Road Capital's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Copland Road Capital's Debt-to-Revenue falls into.



Copland Road Capital Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Copland Road Capital's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Copland Road Capital's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


Copland Road Capital Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Copland Road Capital's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Copland Road Capital (XCNQ:CRCC) Business Description

Traded in Other Exchanges
N/A
Address
217 Queen Street West, Suite 401, Toronto, ON, CAN, M5V 0R2
Copland Road Capital Corp is an investment company. It focuses on making investments in the cannabis industry. It generates revenue from Retail and wholesale, which includes the sale of physical cannabis goods. The company discontinued all its operations.
Executives
Scott Kelly 10% Security Holder, Director

Copland Road Capital (XCNQ:CRCC) Headlines

No Headlines